The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns.
On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies,"...
The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies ...
'There's so many different types of abuse, and it all comes down to the same thing. It's making people nothing. And Fran was nothing. There was never anything nice said about her, everything was negative. And she had to put up with that, and we had to put up with that, until we all sort of believed it, almost.' Preventing the Emotional Abuse and Neglect of People with Intellectual Disability throws light onto the traumatic experiences faced by people with intellectual disability living in disability accommodation services. Through the narratives of nine people with intellectual disability and...
'There's so many different types of abuse, and it all comes down to the same thing. It's making people nothing. And Fran was nothing. There was never ...